RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis

L. J. van der Giessen, J. C. de Jongste, R. Gosselink, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands; Leuven, Belgium)

Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Session: Cystic fibrosis lung disease: molecules images and drugs
Session type: Oral Presentation
Number: 1976
Disease area: Paediatric lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. J. van der Giessen, J. C. de Jongste, R. Gosselink, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands; Leuven, Belgium). RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 1976

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Source: Eur Respir J 2004; 24: 95-100
Year: 2004



Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005



Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014


Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018



Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Source: Eur Respir J 2016; 47: 829-836
Year: 2016



Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002



Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006


A short-term comparison of two methods of sputum expectoration in cystic fibrosis
Source: Eur Respir J 2004; 23: 435-439
Year: 2004



Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008

Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015

Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Pharmacological airway clearance strategies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 239-247
Year: 2011


The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007


Treatment of atelectasis and severe mucus plugging in cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018

Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 529s
Year: 2002

Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014


Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002